Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals Gray Market Peptides: So Much Hype, So Little Data The Peptide Craze Ground Truths Save Peptides Save Peptides FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Major peptide regulatory news this week. The FDA announced on April 15 that it will remove 12 peptides from Category 2 of the 503A bulk drug substances list after seven calendar days.